Baker Avenue Asset Management, LP Exact Sciences Corp Transaction History

Baker Avenue Asset Management, LP

  • $3.41 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$30.35 - $53.15 $485 - $850
16 New
16 $0
Q1 2020

May 14, 2020
SELL
$37.9 - $104.44 $675,302 - $1.86 Million
-17,818 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$77.66 - $99.74 $1.07 Million - $1.38 Million
13,818 Added 345.45%
17,818 $1.65 Million
Q3 2019

Nov 15, 2019
BUY
$90.37 - $122.49 $361,480 - $489,960
4,000 New
4,000 $361,000

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Baker Avenue Asset Management, LP Portfolio

Follow Baker Avenue Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Avenue Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Avenue Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email